000 01653 a2200505 4500
005 20250516092241.0
264 0 _c20121109
008 201211s 0 0 eng d
022 _a1095-6859
024 7 _a10.1016/j.ygyno.2012.05.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHyman, David M
245 0 0 _aOutcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma.
_h[electronic resource]
260 _bGynecologic oncology
_cAug 2012
300 _a224-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aCohort Studies
650 0 4 _aCystadenocarcinoma, Serous
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aGenes, BRCA2
650 0 4 _aGerm-Line Mutation
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aNeoplasm Staging
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
700 1 _aLong, Kara C
700 1 _aTanner, Edward J
700 1 _aGrisham, Rachel N
700 1 _aArnold, Angela G
700 1 _aBhatia, Jasmine
700 1 _aPhillips, Mary F
700 1 _aSpriggs, David R
700 1 _aSoslow, Robert A
700 1 _aKauff, Noah D
700 1 _aLevine, Douglas A
773 0 _tGynecologic oncology
_gvol. 126
_gno. 2
_gp. 224-8
856 4 0 _uhttps://doi.org/10.1016/j.ygyno.2012.05.001
_zAvailable from publisher's website
999 _c21775536
_d21775536